Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

donafenib MeSH Supplementary Concept Data 2025


MeSH Supplementary
donafenib
Unique ID
C000710249
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000710249
Entry Term(s)
2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-(methyl-d3)-
4-(4-(((4-Chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)phenoxy)-N-(2H3)methyl-2-pyridinecarboxamide
CM-4307
Zepsun
Registry Numbers
41XGO0VS1U
Heading Mapped to
*Pyridines
Frequency
12
Note
functions as a multikinase inhibitor
Source
Pharmazie . 2019 Nov 1;74(11):688-693.
Date of Entry
2020/09/03
Revision Date
2022/08/03
donafenib Preferred
4-(4-(((4-Chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)phenoxy)-N-(2H3)methyl-2-pyridinecarboxamide Broader
CM-4307 Narrower
page delivered in 0.006s